131 related articles for article (PubMed ID: 37717380)
1. Discovery of 1,2-diaryl-3-oxopyrazolidin-4-carboxamides as a new class of MurA enzyme inhibitors and characterization of their antibacterial activity.
Wagdy RA; Abutaleb NS; Fathalla RK; Elgammal Y; Weck S; Pal R; Fischer PD; Ducho C; Abadi AH; N Seleem M; Engel M; Abdel-Halim M
Eur J Med Chem; 2023 Dec; 261():115789. PubMed ID: 37717380
[TBL] [Abstract][Full Text] [Related]
2. Identification and Biochemical Characterization of Pyrrolidinediones as Novel Inhibitors of the Bacterial Enzyme MurA.
Fathalla RK; Fröhner W; Bader CD; Fischer PD; Dahlem C; Chatterjee D; Mathea S; Kiemer AK; Arthanari H; Müller R; Abdel-Halim M; Ducho C; Engel M
J Med Chem; 2022 Nov; 65(21):14740-14763. PubMed ID: 36269107
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a Cys115 to Asp substitution in the Escherichia coli cell wall biosynthetic enzyme UDP-GlcNAc enolpyruvyl transferase (MurA) that confers resistance to inactivation by the antibiotic fosfomycin.
Kim DH; Lees WJ; Kempsell KE; Lane WS; Duncan K; Walsh CT
Biochemistry; 1996 Apr; 35(15):4923-8. PubMed ID: 8664284
[TBL] [Abstract][Full Text] [Related]
4. Potential Allylpyrocatechol Derivatives as Antibacterial Agent Against Oral Pathogen of
Kurnia D; Hutabarat GS; Windaryanti D; Herlina T; Herdiyati Y; Satari MH
Drug Des Devel Ther; 2020; 14():2977-2985. PubMed ID: 32801638
[TBL] [Abstract][Full Text] [Related]
5. Investigation of New Inhibitors of UDP-N-Acetylglucosamine Enolpyruvyl Transferase (MurA) by Virtual Screening with Antibacterial Assessment.
Boulhissa I; Chikhi A; Bensegueni A; Ghattas MA; Mokrani EH; Alrawashdeh S; Obaid DEE
Curr Comput Aided Drug Des; 2021; 17(2):214-224. PubMed ID: 32053077
[TBL] [Abstract][Full Text] [Related]
6. Covalent inhibitors of bacterial peptidoglycan biosynthesis enzyme MurA with chloroacetamide warhead.
Grabrijan K; Hrast M; Proj M; Dolšak A; Zdovc I; Imre T; Petri L; Ábrányi-Balogh P; Keserű GM; Gobec S
Eur J Med Chem; 2022 Dec; 243():114752. PubMed ID: 36126388
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of new inhibitors of the Escherichia coli MurA enzyme.
Baum EZ; Montenegro DA; Licata L; Turchi I; Webb GC; Foleno BD; Bush K
Antimicrob Agents Chemother; 2001 Nov; 45(11):3182-8. PubMed ID: 11600375
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo functional activity of Chlamydia MurA, a UDP-N-acetylglucosamine enolpyruvyl transferase involved in peptidoglycan synthesis and fosfomycin resistance.
McCoy AJ; Sandlin RC; Maurelli AT
J Bacteriol; 2003 Feb; 185(4):1218-28. PubMed ID: 12562791
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and structure-activity relationship study of novel quinazolinone-based inhibitors of MurA.
Hrast M; Rožman K; Jukič M; Patin D; Gobec S; Sova M
Bioorg Med Chem Lett; 2017 Aug; 27(15):3529-3533. PubMed ID: 28579123
[TBL] [Abstract][Full Text] [Related]
10. Antibacterial Flavonoids Against Oral Bacteria of Enterococcus Faecalis ATCC 29212 from Sarang Semut (Myrmecodia pendans) and Its Inhibitor Activity Against Enzyme MurA.
Kurnia D; Apriyanti E; Soraya C; Satari MH
Curr Drug Discov Technol; 2019; 16(3):290-296. PubMed ID: 30152286
[TBL] [Abstract][Full Text] [Related]
11. Differential antibacterial properties of the MurA inhibitors terreic acid and fosfomycin.
Olesen SH; Ingles DJ; Yang Y; Schönbrunn E
J Basic Microbiol; 2014 Apr; 54(4):322-6. PubMed ID: 23686727
[TBL] [Abstract][Full Text] [Related]
12. Screening of compound library identifies novel inhibitors against the MurA enzyme of Escherichia coli.
Raina D; Tiwari H; Sharma S; Deepika ; Chinthakindi PK; Nargotra A; Sangwan PL; Eniyan K; Bajpai U; Vishwakarma RA; Khan FG; Saran S; Khan IA
Appl Microbiol Biotechnol; 2021 May; 105(9):3611-3623. PubMed ID: 33860835
[TBL] [Abstract][Full Text] [Related]
13. Identification of a novel UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) from Vibrio fischeri that confers high fosfomycin resistance in Escherichia coli.
Kumar S; Parvathi A; Hernandez RL; Cadle KM; Varela MF
Arch Microbiol; 2009 May; 191(5):425-9. PubMed ID: 19277606
[TBL] [Abstract][Full Text] [Related]
14. Potential of MurA Enzyme and GBAP in Fsr Quorum Sensing System as Antibacterial Drugs Target: In vitro and In silico Study of Antibacterial Compounds from Myrmecodia pendans.
Apriyanti E; Satari MH; Kurnia D
Comb Chem High Throughput Screen; 2021; 24(1):109-118. PubMed ID: 32598250
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationships of tulipalines, tuliposides, and related compounds as inhibitors of MurA.
Mendgen T; Scholz T; Klein CD
Bioorg Med Chem Lett; 2010 Oct; 20(19):5757-62. PubMed ID: 20729083
[TBL] [Abstract][Full Text] [Related]
16. Avenaciolides: potential MurA-targeted inhibitors against peptidoglycan biosynthesis in methicillin-resistant Staphylococcus aureus (MRSA).
Chang CM; Chern J; Chen MY; Huang KF; Chen CH; Yang YL; Wu SH
J Am Chem Soc; 2015 Jan; 137(1):267-75. PubMed ID: 25521652
[TBL] [Abstract][Full Text] [Related]
17. Discovery of new MurA inhibitors using induced-fit simulation and docking.
Rožman K; Lešnik S; Brus B; Hrast M; Sova M; Patin D; Barreteau H; Konc J; Janežič D; Gobec S
Bioorg Med Chem Lett; 2017 Feb; 27(4):944-949. PubMed ID: 28077258
[TBL] [Abstract][Full Text] [Related]
18. Potential Fatty Acid as Antibacterial Agent Against Oral Bacteria of Streptococcus mutans and Streptococcus sanguinis from Basil (Ocimum americanum): In vitro and In silico Studies.
Herdiyati Y; Astrid Y; Shadrina AAN; Wiani I; Satari MH; Kurnia D
Curr Drug Discov Technol; 2021; 18(4):532-541. PubMed ID: 32652913
[TBL] [Abstract][Full Text] [Related]
19. Boswellic acids, as novel inhibitor targeting peptidoglycan biosynthetic enzyme UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) in Escherichia coli.
Raina D; Khan FG; Tiwari H; Sangwan PL; Nargotra A; Kumar V; Khan IA; Saran S
Arch Microbiol; 2022 Jul; 204(8):472. PubMed ID: 35819545
[TBL] [Abstract][Full Text] [Related]
20. Asp50Glu mutation in MurA results in fosfomycin resistance in Enterococcus faecium.
Xin L; Hu Z; Han R; Xu X; Wang C; Li D; Guo Y; Hu F
J Glob Antimicrob Resist; 2022 Sep; 30():50-55. PubMed ID: 35660662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
